|please help me
Apr 15, 2004
I am at present on combivir and viramune I live iN Spain. I would like you to advice me if there are better medications to control lypodystrophy. To commence treatment I was on epivir zerit and viracept. I told my doctor I was experiencing serious lipodystrophy on my stomach face arms and legs. She changed my treatment to my current one of viramune and combivir. I have only been taking it for about 6 weeks but am feeling tired and out of breath. Please advice
Response from Dr. Moyle
Sometimes treatments with AZT (such as combivir) can give fatigue and may also trigger anemia (which could cause shortness of breath). Your doctor should check your haemoglobin. There is limited evidence to say that switching d4T to AZT helps improve lipodystrophy. The bulk of evidence for switching is from d4T (or AZT) to abacavir. Aside from an allergic reaction in 5% of persons abacavir is a generally very well tolerated drug and will soon be available as a single once daily tablet with 3TC (kind of like combivir). Switching over to this drug from AZT may be the best option in the long term Regards Graeme Moyle
Zerit vs. Ziagen/Viread
Abacavir vs Tenofovir
- How Much Body Fluid Is Actually Needed To Transmit Hiv?
- Can Herpes Infection Cause A Positive Hiv Test?
- My Husband Is Hiv Positive
- Can You Have Unprotected Sex With Someone Who Has Hiv But An Undetectable Virus Load?
- Peripheral Neuropathy Causing The Feeling Of Cold Feet
- How Can A Person Be Hiv Positive But Test Negative?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.